1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Stability testing of new drug substances and products Q1A(R2). Available at: https://database.ich.org/sites/default/files/Q1A_R2_Guideline.pdf Accessed 16 June 2022.
2. World Health Organization. WHO guidelines of stability testing of active pharmaceutical ingredients and finished pharmaceutical products. Technical Report Series, No 1010, 2018 Annex 10. Available at:https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1010-annex10-who-stability-testing-of-active-pharmaceutical-ingredients.pdf Accessed 16 June 2022.
3. In-use stability studies: guidelines and challenges;Chavda;Drug Dev Ind Pharmacy,2021
4. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on in-use stability testing of human medicinal products. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-use-stability-testing-human-medicinal-products_en.pdf Accessed 16 June 2022.
5. European Agency for the Evaluation of Medicinal Products. Committee for Veterinary Medicinal Products. Note for guidance on in-use stability testing of veterinary medicinal products (excluding immunological veterinary medicinal products). Available at:https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-use-stability-testing-veterinary-medicinal-products-excluding-immunological-veterinary_en.pdf Accessed 16 June 2022.